Recent data have not only shown that loss of FAT1 expression leads to increased YAP/TAZ activity and expression of YAP/TAZ target genes but also that increased YAP/TAZ activity is responsible for increased tumor growth, EMT, metastasis and resistance to therapy in tumors lacking FAT1 [2,3,8]. The gene discussed is WWTR1; the disease is neoplasm.